Which Lipofit/LipoFit products (by manufacturer and SKU) have independent lab testing or FDA reviews?
Executive summary
LipoFit Turbo — a weight‑loss product marketed as a dietary supplement — has been the subject of direct FDA laboratory analysis, which found concealed prescription drugs in the product [1]. Separately, “LipoFit” or “lipoFIT” appears as the name of validated laboratory diagnostic assays offered by manufacturers such as ARUP Laboratories (test IDs listed in their directory) and Numares (AXINON® lipoFIT®), but those are clinical tests for lipoprotein particles rather than commercial consumer supplements [2] [3] [4] [5].
1. FDA analysis of a supplement named LipoFit Turbo: what was tested and what was found
The U.S. Food and Drug Administration publicly advised consumers not to buy or use LipoFit Turbo after its laboratory analysis confirmed the presence of undeclared pharmaceutical ingredients — specifically sibutramine, metformin, fluoxetine and furosemide — none of which were listed on the product label [1]. That FDA notification constitutes an agency laboratory review of that product batch and a public health advisory; the agency also warns it cannot test every marketed supplement and encourages reporting of adverse events [1].
2. “LipoFit” as a clinical laboratory assay — ARUP’s LipoFit by NMR (manufacturer and catalog IDs)
ARUP Laboratories lists “LipoFit by NMR” in its test directory as a clinical assay for lipoprotein particle number and subfractions, and the ARUP pages identify specific test entries (for example, the full LipoFit test and a “Particle Count Only” variant) with their internal test identifiers in the public test directory [2] [3]. ARUP further notes its accreditations (CAP, CLIA, ISO) and that some ARUP assays are non‑FDA‑approved test methods offered under appropriate labeling — information that frames these entries as regulated laboratory services rather than consumer supplements [4] [2].
3. Numares’ AXINON® lipoFIT® assay — CE marking and platform context (manufacturer and product name)
Numares markets the AXINON® lipoFIT®‑S100 assay as an automated NMR‑based lipoprotein test for cardiovascular risk assessment; the company states the assay is CE‑marked and built on an AXINON system using “FDA‑cleared technology” as its platform language, but this is a diagnostic device/assay claim, not an FDA approval of a consumer supplement product [5]. The Numares material positions AXINON lipoFIT as a laboratory product for clinical labs rather than a retail supplement SKU [5].
4. Independent third‑party testing landscape: what exists and what the record lacks for consumer LipoFit products
Independent testing organizations (Labdoor, ConsumerLab, and others) perform market buys and chemistry panels to verify supplement content and purity, and third‑party certification is widely recommended because FDA premarket oversight of supplements is limited under DSHEA [6] [7] [8]. The provided sources do not show published Labdoor or ConsumerLab reports for any retail supplement SKU named “LipoFit” beyond the FDA’s LipoFit Turbo action, so there is no documented independent lab report in these sources for other LipoFit‑branded consumer supplements [6] [9] [7].
5. How to interpret the different uses of the name “LipoFit” and where gaps remain
The evidence in the record separates two things that sound alike: (a) an FDA laboratory review and public safety notice about a retail weight‑loss product called LipoFit Turbo that contained undeclared pharmaceuticals [1], and (b) clinically validated laboratory assays named LipoFit or lipoFIT used by diagnostic labs and manufacturers such as ARUP and Numares [2] [3] [5]. The sources do not provide SKUs, manufacturer lot numbers, or independent third‑party certificate‑of‑analysis documents for retail LipoFit supplements other than the FDA’s analysis of LipoFit Turbo, nor do they show ConsumerLab or Labdoor test reports on a broad line of “LipoFit” consumer products [1] [6] [9].
6. Bottom line: what can be confidently stated and what cannot
Confidently stated: the FDA laboratory analyzed and publicly warned about LipoFit Turbo because it contained undeclared prescription drugs [1]; ARUP and Numares offer clinical tests named LipoFit/lipoFIT with documented test listings and accreditations [2] [3] [5] [4]. Not established in the supplied reporting: any other specific retail LipoFit/LipoFit SKUs that have independent third‑party lab test reports or FDA reviews beyond the LipoFit Turbo action — the record lacks published independent certificates or retail SKUs beyond what the FDA disclosed [1] [6].